Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Parasit Vectors ; 15(1): 202, 2022 Jun 13.
Article in English | MEDLINE | ID: mdl-35698163

ABSTRACT

BACKGROUND: Zoonotic leishmaniosis caused by Leishmania infantum is endemic in several countries of the Mediterranean Basin, Latin America, and Asia. Dogs are the main hosts and reservoirs of human infection. Thus, from a One Health perspective, early diagnosis of Leishmania infection in dogs is essential to control the dissemination of the parasite among other dogs and to humans. The aim of this study was to estimate the diagnosis accuracy of three serological tests to detect antibodies to Leishmania in dogs from two endemic settings using Bayesian latent class models (BLCM). METHODS: A total of 378 dogs from two Portuguese and Brazilian endemic areas of leishmaniosis (194 animals from Portugal and 184 from Brazil) were screened. Detection of anti-Leishmania antibodies was performed using two commercial ELISA (L. infantum IgG-ELISA® and EIE-LVC®) and a rapid immunochromatographic test (DPP-LVC®). Bayesian latent class models were used to estimate Leishmania infection prevalence, together with sensitivities and specificities of the three diagnostic tests, in the two dog populations simultaneously. Predictive values were also calculated. Credibility intervals (CI) were obtained, considering different types of prior information. RESULTS: A posterior median Leishmania seroprevalence of 13.4% (95% CI 9.0-18.7) and of 21.6% (15.0-28.3) was estimated to the Portuguese and Brazilian dog subpopulations, respectively. The Bayesian analysis indicated that all tests were highly specific (specificity above 90%), and that the DPP-LVC® was more sensitive (96.6%; 83.1-99.9) than both ELISAs in the Portuguese subpopulation, while in the Brazilian subpopulation, EIE-LVC® and L. infantum IgG-ELISA®, had the highest sensitivity (88.2%; 73.7-97.0) and specificity (98.7%; 95.1-99.9), respectively. CONCLUSIONS: In general, the levels of diagnosis accuracy of the three serological tests to detect Leishmania antibodies assessed by BLCM indicate their utility in canine epidemiological studies. The same approach should be used to assess the performance of these techniques in the clinical management of infected and sick dogs using representative samples from the wide spectrum of clinical situations, namely from subclinical infection to manifest disease. The low positive predictive value of the serological tests used in the current protocol of the Brazilian Ministry of Health suggests that they should not be used individually and may not be sufficient to target reservoir-based control interventions.


Subject(s)
Dog Diseases , Leishmania infantum , Leishmaniasis, Visceral , Leishmaniasis , Animals , Antibodies, Protozoan , Bayes Theorem , Brazil/epidemiology , Dog Diseases/diagnosis , Dog Diseases/epidemiology , Dog Diseases/parasitology , Dogs , Enzyme-Linked Immunosorbent Assay/methods , Immunoglobulin G , Latent Class Analysis , Leishmaniasis/diagnosis , Leishmaniasis/epidemiology , Leishmaniasis/veterinary , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/epidemiology , Leishmaniasis, Visceral/veterinary , Portugal/epidemiology , Seroepidemiologic Studies , Serologic Tests/methods
2.
Biomed Pharmacother ; 142: 111993, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34364045

ABSTRACT

Superoxide dismutase 2 (SOD2) is an antioxidant enzyme that appears phylogenetically conserved. However, functional Sod2 polymorphisms have been studied, and the specific polymorphisms are related to activity alterations of the SOD2 enzyme. An example of a polymorphism of SOD2 is Val16Ala (rs4880), which has been identified in exon 2 of the human Sod2 gene. This polymorphism is recognized as a single nucleotide polymorphism (SNP) and alters the conformation of SOD2. Additionally, recent studies have shown that the Ala16 Val polymorphism in Sod2 can be related to different pathological diseases. In these terms, the objective of the present study was to evaluate whether the polymorphism of SOD2 in Val16Ala (rs4880) influences the motility and vigor of X- and Y-bearing sperm at different pH values promoting sperm selection. We found that polymorphism rs4880 at normal pH conditions can result in alterations in the activity of superoxide dismutase in the sperm through different assay analyses. Moreover, compelling modulation evidence indicates that this effect could also mediate seminal plasma redox alterations and consequently can play an important role in sperm physiology, fertilization, and postfertilization.


Subject(s)
Sperm Motility/physiology , Spermatozoa/physiology , Superoxide Dismutase/genetics , Humans , Hydrogen-Ion Concentration , Male , Oxidation-Reduction , Polymorphism, Single Nucleotide
3.
PLos ONE ; 16(8)Aug.6.2021.
Article in English | Sec. Est. Saúde SP | ID: biblio-1526975

ABSTRACT

Mozambique introduced the monovalent rotavirus vaccine (Rotarix®, GSK Biologicals, Rixensart, Belgium) in September 2015. Previous analysis, showed that Nampula province continues reporting a high frequency of Rotavirus A (RVA) infection and the emergence of G9P[6], G9P[4] and G3P[4] genotypes. This analysis aimed to determine the RVA frequency; risk factors; genotype distribution by vaccination status and age between pre- and post-vaccine periods in children under-five years old with diarrhea in Nampula...


Subject(s)
Humans , Rotavirus Infections , Vaccination , Rotavirus , Mozambique
4.
Int J Health Plann Manage ; 34(4): 1277-1289, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30994221

ABSTRACT

INTRODUCTION: The judicialization of health arose following the possibility of judicially demanding the right to health before national and international courts. In the case of Colombia, health litigation is done through a constitutional tool called the tutela action, which allows for the immediate protection of fundamental rights. METHODS: A retrospective cross-sectional study using a probabilistic stratified sample of 1031 users of the tutela actions, in Medellín, Colombia, between 2011 and 2014. Bivariate and multivariate analyses were performed, using statistical tests and multiple logistic regression models. RESULTS: According to the respondents, 95.9% of the tutela actions succeeded in favour of the applicant. On average, the judicial process took 10.96 days (SD = 8.09). After the favourable decision of the tutela action, access to health care followed in 76.2% of cases, partial access was found for 14.0% (median, 10 d), and in 9.8% of cases, claimants had not received access to the health care they sought. CONCLUSION: The tutela action is an essential constitutional mechanism that guarantees the access to health services. However, it must be strengthened from the legal point of view through the implementation of monitoring and control actions and by imposing the sanctioning measures and deadlines established in existing legislation.


Subject(s)
Jurisprudence , Right to Health/legislation & jurisprudence , Colombia , Cross-Sectional Studies , Delivery of Health Care/legislation & jurisprudence , Delivery of Health Care/organization & administration , Health Services Accessibility/legislation & jurisprudence , Health Services Accessibility/statistics & numerical data , Humans , Male , Middle Aged , Retrospective Studies , Right to Health/statistics & numerical data
5.
Rev Soc Bras Med Trop ; 45(3): 369-74, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22760138

ABSTRACT

INTRODUCTION: Malaria during pregnancy remains a serious public health problem. The aim of this study was to establish the prevalence and possible risk factors for malaria in pregnant women attending antenatal care at Augusto Ngangula Specialized General Hospital in Luanda, Angola. METHODS: Pregnant women (679 total) who attended antenatal care from April to September 2008 were included in the study after signing informed consent. For each participant, the social-demographic profile and malaria and obstetric histories were investigated via a questionnaire. Diagnosis was made by optic microscopy, and hemoglobin concentration measured. The associations between age, parity, gestational age, residence, schooling, malaria during gravity, anemia and treatment with incidence of Plasmodium falciparum infection were analyzed through logistic regression. RESULTS: During the period of study, 74 (10.9%) out of 679 women were infected by P. falciparum. The average concentration of hemoglobin was 11.1 ± 0.07 g/dL, and there were significant associations between the history of malaria during pregnancy, P. falciparum infection (p<0.01) and anemia at the time of observation (p<0.001). CONCLUSIONS: Previous history of malaria during pregnancy represents a risk factor for current infection and anemia was an important complication associated with malaria, even in women who were treated with sulfadoxine-pyrimethamine during pregnancy.


Subject(s)
Malaria, Falciparum/epidemiology , Pregnancy Complications, Parasitic/epidemiology , Prenatal Diagnosis/statistics & numerical data , Adolescent , Adult , Angola/epidemiology , Antimalarials/therapeutic use , Child , Drug Combinations , Female , Humans , Malaria, Falciparum/diagnosis , Malaria, Falciparum/drug therapy , Middle Aged , Pregnancy , Pregnancy Complications, Parasitic/diagnosis , Pregnancy Complications, Parasitic/drug therapy , Prevalence , Pyrimethamine/therapeutic use , Risk Factors , Socioeconomic Factors , Sulfadoxine/therapeutic use , Young Adult
6.
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;45(3): 369-374, May-June 2012. graf, tab
Article in English | LILACS | ID: lil-640437

ABSTRACT

INTRODUCTION: Malaria during pregnancy remains a serious public health problem. The aim of this study was to establish the prevalence and possible risk factors for malaria in pregnant women attending antenatal care at Augusto Ngangula Specialized General Hospital in Luanda, Angola. METHODS: Pregnant women (679 total) who attended antenatal care from April to September 2008 were included in the study after signing informed consent. For each participant, the social-demographic profile and malaria and obstetric histories were investigated via a questionnaire. Diagnosis was made by optic microscopy, and hemoglobin concentration measured. The associations between age, parity, gestational age, residence, schooling, malaria during gravity, anemia and treatment with incidence of Plasmodium falciparum infection were analyzed through logistic regression. RESULTS: During the period of study, 74 (10.9%) out of 679 women were infected by P. falciparum. The average concentration of hemoglobin was 11.1 ± 0.07g/dL, and there were significant associations between the history of malaria during pregnancy, P. falciparum infection (p<0.01) and anemia at the time of observation (p<0.001). CONCLUSIONS: Previous history of malaria during pregnancy represents a risk factor for current infection and anemia was an important complication associated with malaria, even in women who were treated with sulfadoxine-pyrimethamine during pregnancy.


INTRODUÇÃO: A malária na gravidez continua a ser um grave problema de saúde pública. O objetivo deste estudo foi determinar a prevalência e possíveis fatores de risco para a malária, em mulheres grávidas que foram atendidas em consultas pré-natal, no Hospital Geral Especializado Augusto Ngangula, em Luanda, Angola. MÉTODOS: De abril a setembro de 2008, 679 mulheres grávidas foram envolvidas no estudo após consentimento informado. O perfil sócio demográfico e história de malária e obstetrícia foram investigados através de um questionário. O diagnóstico foi efetuado por microscopia óptica e determinou-se ainda as concentrações da hemoglobina. Através da regressão logística foi analisada a associação entre a idade, paridade, tempo de gestação, residência, escolaridade, malária durante a gravidez, anemia e tratamento com a infecção por Plasmodium falciparum. RESULTADOS: Setenta e quatro (10,9%) das 679 mulheres estavam infectadas com P. falciparum. O valor médio da concentração da hemoglobina foi de 11,1 ± 0,07g/dL, encontrando-se uma associação significativa entre história de malária na gravidez e infecção por P. falciparum (p<0,01) e anemia no momento da observação (p<0.001). CONCLUSÕES: A história de malária anterior na gravidez foi um fator de risco para uma infecção atual e a anemia uma complicação importante associada à malária, mesmo em mulheres que receberam tratamento durante a gravidez com sulfadoxina-pirimetamina.


Subject(s)
Adolescent , Adult , Child , Female , Humans , Middle Aged , Pregnancy , Young Adult , Malaria, Falciparum/epidemiology , Pregnancy Complications, Parasitic/epidemiology , Prenatal Diagnosis/statistics & numerical data , Angola/epidemiology , Antimalarials/therapeutic use , Drug Combinations , Malaria, Falciparum/diagnosis , Malaria, Falciparum/drug therapy , Prevalence , Pregnancy Complications, Parasitic/diagnosis , Pregnancy Complications, Parasitic/drug therapy , Pyrimethamine/therapeutic use , Risk Factors , Socioeconomic Factors , Sulfadoxine/therapeutic use
7.
Mem Inst Oswaldo Cruz ; 105(1): 92-8, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20209336

ABSTRACT

Hepatitis C virus (HCV) is a major cause of liver disease throughout the world. The NS5A and E2 proteins of HCV genotype 1 were reported to inhibit the double-stranded (ds) RNA-dependent protein kinase (PKR), which is involved in the cellular antiviral response induced by interferon (IFN). The response to IFN therapy is quite different between genotypes, with response rates among patients infected with types 2 and 3 that are two-three-fold higher than in patients infected with type 1. Interestingly, a significant percentage of HCV genotype 3-infected patients do not respond to treatment at all. The aim of this paper was to analyse the sequences of fragments of the E2 and NS5A regions from 33 outpatients infected with genotype 3a, including patients that have responded (SVR) or not responded (NR) to treatment. HCV RNA was extracted and amplified with specific primers for the NS5A and E2 regions and the PCR products were then sequenced. The sequences obtained covered amino acids (aa) 636-708 in E2 and in NS5A [including the IFN sensitivity determining region (ISDR), PKR-binding domain and extended V3 region)]. In the E2 and NS5A regions, we did observe aa changes among patients, but these changes were not statistically significant between the SVR and NR groups. In conclusion, our results suggest that the ISDR domain is not predictive of treatment success in patients infected with HCV genotype 3a.


Subject(s)
Hepacivirus/genetics , Hepatitis C, Chronic/virology , RNA, Viral/genetics , Viral Envelope Proteins/genetics , Viral Nonstructural Proteins/genetics , Adult , Amino Acid Sequence , Antiviral Agents/therapeutic use , Female , Genotype , Hepatitis C, Chronic/drug therapy , Humans , Interferon-alpha/therapeutic use , Male , Molecular Sequence Data , Polymerase Chain Reaction , Ribavirin/therapeutic use
8.
Mem. Inst. Oswaldo Cruz ; 105(1): 92-98, Feb. 2010. tab, ilus
Article in English | LILACS | ID: lil-539301

ABSTRACT

Hepatitis C virus (HCV) is a major cause of liver disease throughout the world. The NS5A and E2 proteins of HCV genotype 1 were reported to inhibit the double-stranded (ds) RNA-dependent protein kinase (PKR), which is involved in the cellular antiviral response induced by interferon (IFN). The response to IFN therapy is quite different between genotypes, with response rates among patients infected with types 2 and 3 that are two-three-fold higher than in patients infected with type 1. Interestingly, a significant percentage of HCV genotype 3-infected patients do not respond to treatment at all. The aim of this paper was to analyse the sequences of fragments of the E2 and NS5A regions from 33 outpatients infected with genotype 3a, including patients that have responded (SVR) or not responded (NR) to treatment. HCV RNA was extracted and amplified with specific primers for the NS5A and E2 regions and the PCR products were then sequenced. The sequences obtained covered amino acids (aa) 636-708 in E2 and in NS5A [including the IFN sensitivity determining region (ISDR), PKR-binding domain and extended V3 region)]. In the E2 and NS5A regions, we did observe aa changes among patients, but these changes were not statistically significant between the SVR and NR groups. In conclusion, our results suggest that the ISDR domain is not predictive of treatment success in patients infected with HCV genotype 3a.


Subject(s)
Adult , Female , Humans , Male , Hepacivirus/genetics , Hepatitis C, Chronic/virology , RNA, Viral/genetics , Viral Envelope Proteins/genetics , Viral Nonstructural Proteins/genetics , Amino Acid Sequence , Antiviral Agents/therapeutic use , Genotype , Hepatitis C, Chronic/drug therapy , Interferon-alpha/therapeutic use , Molecular Sequence Data , Polymerase Chain Reaction , Ribavirin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL